Brazil's Anvisa thinks both big and small on medtech GMP regulatory changes
This article was originally published in SRA
Executive Summary
Brazil's medicines and medical devices regulatory authority, Anvisa, is not overlooking the needs of smaller device manufacturers as it moves to simplify and align its regulatory processes with those of established major countries.